161 related articles for article (PubMed ID: 22906740)
21. A novel mechanism for the selection of isotype-specific antibody responses: the role of intestinal T cells in the regulation of IgA synthesis by the anti-suppressor circuit.
Ernst PB; Maeba J; Lee SI; Paraskevas F
Immunology; 1988 Sep; 65(1):59-66. PubMed ID: 2972602
[TBL] [Abstract][Full Text] [Related]
22. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
[TBL] [Abstract][Full Text] [Related]
23. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
24. The distribution of leucocyte subsets in the small intestine of healthy cats.
Waly N; Gruffydd-Jones TJ; Stokes CR; Day MJ
J Comp Pathol; 2001; 124(2-3):172-82. PubMed ID: 11222015
[TBL] [Abstract][Full Text] [Related]
25. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.
Coffin SE; Clark SL; Bos NA; Brubaker JO; Offit PA
J Immunol; 1999 Sep; 163(6):3064-70. PubMed ID: 10477570
[TBL] [Abstract][Full Text] [Related]
26. The role of non-B cells in localizing an IgA plasma cell response in the intestine.
Dunkley ML; Husband AJ
Reg Immunol; 1990-1991; 3(6):336-40. PubMed ID: 2132758
[TBL] [Abstract][Full Text] [Related]
27. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.
Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M
Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698
[TBL] [Abstract][Full Text] [Related]
28. Selective chemotaxis of subsets of B lymphocytes from gut-associated lymphoid tissue and its implications for the recruitment of mucosal plasma cells.
Czinn SJ; Lamm ME
J Immunol; 1986 May; 136(10):3607-11. PubMed ID: 3486216
[TBL] [Abstract][Full Text] [Related]
29. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
30. Tolerance and immunity in the intestinal immune system.
Nagler-Anderson C
Crit Rev Immunol; 2000; 20(2):103-20. PubMed ID: 10872893
[TBL] [Abstract][Full Text] [Related]
31. Regulatory activity of the human CD8+ cell subset: a comparison of CD8+ cells from the intestinal lamina propria and blood.
Lee A; Sugerman H; Elson CO
Eur J Immunol; 1988 Jan; 18(1):21-7. PubMed ID: 2964373
[TBL] [Abstract][Full Text] [Related]
32. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.
Chen C; Qu QX; Huang JA; Zhu YB; Ge Y; Wang Q; Zhang XG
Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283
[TBL] [Abstract][Full Text] [Related]
33. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
Yurchenko E; Levings MK; Piccirillo CA
Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
[TBL] [Abstract][Full Text] [Related]
34. Mucosal addressin cell-adhesion molecule-1 controls plasma-cell migration and function in the small intestine of mice.
Schippers A; Leuker C; Pabst O; Kochut A; Prochnow B; Gruber AD; Leung E; Krissansen GW; Wagner N; Müller W
Gastroenterology; 2009 Sep; 137(3):924-33. PubMed ID: 19450594
[TBL] [Abstract][Full Text] [Related]
35. Intestinal CD103+ dendritic cells: master regulators of tolerance?
Scott CL; Aumeunier AM; Mowat AM
Trends Immunol; 2011 Sep; 32(9):412-9. PubMed ID: 21816673
[TBL] [Abstract][Full Text] [Related]
36. The PD-1/PD-Ls pathway and autoimmune diseases.
Dai S; Jia R; Zhang X; Fang Q; Huang L
Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
[TBL] [Abstract][Full Text] [Related]
37. Regionalization of pIgR expression in the mucosa of mouse small intestine.
Reséndiz-Albor AA; Reina-Garfias H; Rojas-Hernández S; Jarillo-Luna A; Rivera-Aguilar V; Miliar-García A; Campos-Rodríguez R
Immunol Lett; 2010 Jan; 128(1):59-67. PubMed ID: 19925828
[TBL] [Abstract][Full Text] [Related]
38. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis.
Alvarez IB; Pasquinelli V; Jurado JO; Abbate E; Musella RM; de la Barrera SS; García VE
J Infect Dis; 2010 Aug; 202(4):524-32. PubMed ID: 20617899
[TBL] [Abstract][Full Text] [Related]
39. PD-L1 expression on tolerogenic APCs is controlled by STAT-3.
Wölfle SJ; Strebovsky J; Bartz H; Sähr A; Arnold C; Kaiser C; Dalpke AH; Heeg K
Eur J Immunol; 2011 Feb; 41(2):413-24. PubMed ID: 21268011
[TBL] [Abstract][Full Text] [Related]
40. Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.
Blake SJ; Ching AL; Kenna TJ; Galea R; Large J; Yagita H; Steptoe RJ
PLoS One; 2015; 10(3):e0119483. PubMed ID: 25741704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
